A detailed history of Nemes Rush Group LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Nemes Rush Group LLC holds 191 shares of ZTS stock, worth $33,459. This represents 0.0% of its overall portfolio holdings.

Number of Shares
191
Previous 789 75.79%
Holding current value
$33,459
Previous $134 Million 75.2%
% of portfolio
0.0%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$145.54 - $178.83 $87,032 - $106,940
-598 Reduced 75.79%
191 $33.1 Million
Q1 2024

May 15, 2024

SELL
$165.67 - $199.94 $501,317 - $605,018
-3,026 Reduced 79.32%
789 $134 Million
Q4 2023

Feb 09, 2024

SELL
$151.44 - $200.09 $605 - $800
-4 Reduced 0.1%
3,815 $753 Million
Q3 2023

Nov 09, 2023

BUY
$167.14 - $192.77 $44,292 - $51,084
265 Added 7.46%
3,819 $664 Million
Q2 2023

Aug 02, 2023

BUY
$160.94 - $186.23 $571,980 - $661,861
3,554 New
3,554 $612 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Nemes Rush Group LLC Portfolio

Follow Nemes Rush Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nemes Rush Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nemes Rush Group LLC with notifications on news.